Oral Abstract Session:
217. Late Breaker Oral Abstracts
Saturday, October 29, 2016: 10:30 AM-12:00 PM
Room: 283-285

Learning Objectives:

-

Tracks: Trainee, Pediatric ID, Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Roberta DeBiasi, MD, MS, Children's National Health System and Scott Fridkin, MD, FIDSA, Centers for Disease Control and Prevention

Presentations:
10:30 AM
LB-1
Diagnostic Performance of Zika Virus RNA PCR in Urine Samples
Loubiela Joseph, MSc ; Samantha Manuel, Msc ; Chris Roggeveen, MD ; Liane Virginia-Cova, MSc ; Radjin Steingrover, MD
10:40 AM
LB-2
MORTALITY IN NEWBORNS WITH MICROCEPHALY DUE TO MATERNAL ZIKA VIRUS INFECTION IN RIO GRANDE DO NORTE STATE – NORTHEAST BRAZIL: A CROSS-SECTIONAL ANALYSIS
Nilson Nogueira Mendes Neto, MS ; Jessika Thais Da Silva Maia, MS ; Daniel Duarte Rolim, MS ; S. Jayne Alves Vidal, Nurse ; Tatyana Vidal Mendes, Nurse ; Marcelo Rodrigues Zacarkim, MD ; Igor Thiago Queiroz, MD, PhD ; David Pierre, MD ; Luiz Alberto Carneiro Marinho, M.D., PhD ; Thiago Gomes Da Trindade, M.D., PhD
10:50 AM
LB-3
A Case-control investigation of Guillain-Barré Syndrome during an outbreak of Zika virus infection — Barranquilla, Colombia, 2015–2016
Jorge Salinas, MD ; Diana Walteros, MD ; Ashley Styczynski, MD, MPH ; Flavio Garzon, MD ; Hernan Quijada, DDS ; Elsa Bravo, BSc ; Javier Madero, RN ; Jorge Acosta-Reyes, MD, MSc ; Christina Renquist, MPH ; Marcela Mercado, BSc ; Ibrahim Zaganjor, MPH ; Maritza Gonzalez, MD, MPH ; Alma Solano, MD ; Martha Ospina, MD, MSc ; James Sejvar, MD ; Pablo Chaparro, MD, PhD
11:00 AM
LB-4
Evaluating Healthcare Workers for Acquisition of Zika ‎Virus While Providing Critical Care
Shannon Novosad, MD, MPH ; Bryan E. Christensen, PhD, MEPC ; J. Erin Staples, MD, PhD ; Allyn Nakashima, MD ; Kimberly Christensen, BS ; Annette Atkinson, MS, M(ASCP) ; WM Bryan Burk, BA ; Brigette Beyer, PA-C, MPH ; Brook Vietor, MS, APRN ; Robert Mccullough, RN ; Kathy Seiber, MS ; Jeanmarie Mayer, MD ; Scott Fridkin, MD, FIDSA ; Michael Rubin, MD, PhD, FIDSA
11:10 AM
LB-5
BCX4430, a Broad-Spectrum Adenosine Analog Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus.
So-Yon Lim, Ph.D. ; Christa Osuna, Ph.D., M.P.H. ; Ray Taylor, MBA ; Amanda Mathis, Ph.D. ; Vivek Kamath, Ph.D. ; Elliot Berger, Ph.D. ; YS Babu, PhD ; William Sheridan, MB BS ; James Whitney, Ph.D.
11:20 AM
LB-6
Primary Efficacy Endpoint and Safety Results of Ibalizumab (IBA) in a Phase 3 Study of Heavily Treatment-Experienced Patients with Multi-Drug Resistant (MDR) HIV-1 Infection
Jacob Lalezari, MD ; W Jeffery Fessel, MD ; Shannon Schrader, MD ; Princy Kumar, M.D. ; Gary Richmond, MD ; Christian Marsolais, PhD ; Steven Weinheimer, PhD ; Stanley Lewis, MD
11:30 AM
LB-7
Meropenem-Vaborbactam (M-V) Compared with Piperacillin-Tazobactam (P-T) in the Treatment of Adults with Complicated Urinary Tract Infections (cUTI), including Acute Pyelonephritis (AP) in a Phase 3 Randomized, Double-blind, Double-dummy Trial (TANGO 1)
Jeff Loutit, MBChB ; Karen Fusaro, BA ; Shu Zhang, PhD ; Elizabeth Morgan, BS ; Elizabeth Alexander, MD, MSc. ; David Griffith, BS ; Olga Lomovskaya, PhD ; Michael N. Dudley, Pharm.D.
11:40 AM
LB-8
Rapid Emergence of Resistance Among Gonorrhea Isolates in Southern Ohio
Thomas Herchline, M.D., FIDSA ; Peter Greene, Public Health Intern
11:50 AM
LB-9
A Large and Primarily Community Associated Outbreak of Elizabethkingia anophelis Infections, Wisconsin, 2015-2016
Lina I Elbadawi, MD, MS ; Gwen Borlaug, CIC, MPH ; Kristin Gundlach, BS ; Timothy Monson, MS ; Judith Noble-Wang, PhD ; Heather Moulton-Meissner, PHD ; Uzma Ansari, MS ; Jonathan S. Yoder, MSW, MPH ; Matthew Wise, PhD ; John R Mcquiston, PhD ; Alexander Kallen, MD, MPH ; Jeffrey P Davis, MD ; Maroya Spalding Walters, PhD

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Oral Abstract Session
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.